Teleflex ROE 2010-2025 | TFX
Current and historical return on equity (ROE) values for Teleflex (TFX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Teleflex ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-06-30 | $0.19B | $4.24B | 4.49% |
| 2025-03-31 | $0.15B | $4.10B | 3.42% |
| 2024-12-31 | $0.07B | $4.28B | 1.55% |
| 2024-09-30 | $0.24B | $4.48B | 5.27% |
| 2024-06-30 | $0.26B | $4.56B | 5.90% |
| 2024-03-31 | $0.29B | $4.50B | 6.73% |
| 2023-12-31 | $0.36B | $4.44B | 8.34% |
| 2023-09-30 | $0.40B | $4.31B | 9.70% |
| 2023-06-30 | $0.37B | $4.22B | 9.09% |
| 2023-03-31 | $0.36B | $4.11B | 9.17% |
| 2022-12-31 | $0.36B | $4.02B | 9.35% |
| 2022-09-30 | $0.41B | $3.90B | 10.80% |
| 2022-06-30 | $0.51B | $3.85B | 13.54% |
| 2022-03-31 | $0.49B | $3.80B | 13.27% |
| 2021-12-31 | $0.49B | $3.76B | 13.61% |
| 2021-09-30 | $0.43B | $3.66B | 12.52% |
| 2021-06-30 | $0.35B | $3.47B | 10.47% |
| 2021-03-31 | $0.28B | $3.38B | 8.56% |
| 2020-12-31 | $0.34B | $3.34B | 10.52% |
| 2020-09-30 | $0.37B | $3.24B | 11.85% |
| 2020-06-30 | $0.48B | $3.10B | 15.96% |
| 2020-03-31 | $0.55B | $3.07B | 19.05% |
| 2019-12-31 | $0.46B | $2.98B | 16.66% |
| 2019-09-30 | $0.44B | $2.85B | 16.71% |
| 2019-06-30 | $0.27B | $2.67B | 10.58% |
| 2019-03-31 | $0.19B | $2.57B | 7.44% |
| 2018-12-31 | $0.20B | $2.54B | 8.05% |
| 2018-09-30 | $0.07B | $2.51B | 2.74% |
| 2018-06-30 | $0.09B | $2.43B | 3.56% |
| 2018-03-31 | $0.17B | $2.56B | 6.84% |
| 2017-12-31 | $0.15B | $2.43B | 6.41% |
| 2017-09-30 | $0.26B | $2.47B | 11.14% |
| 2017-06-30 | $0.25B | $2.36B | 11.03% |
| 2017-03-31 | $0.23B | $2.22B | 10.45% |
| 2016-12-31 | $0.24B | $2.14B | 11.16% |
| 2016-09-30 | $0.28B | $2.17B | 13.25% |
| 2016-06-30 | $0.27B | $2.12B | 13.37% |
| 2016-03-31 | $0.26B | $2.06B | 13.01% |
| 2015-12-31 | $0.25B | $2.01B | 12.67% |
| 2015-09-30 | $0.20B | $1.94B | 10.21% |
| 2015-06-30 | $0.19B | $1.92B | 9.85% |
| 2015-03-31 | $0.19B | $1.86B | 9.87% |
| 2014-12-31 | $0.19B | $1.91B | 9.61% |
| 2014-09-30 | $0.17B | $1.98B | 8.79% |
| 2014-06-30 | $0.16B | $1.98B | 8.51% |
| 2014-03-31 | $0.16B | $1.95B | 8.45% |
| 2013-12-31 | $0.15B | $1.92B | 8.21% |
| 2013-09-30 | $0.15B | $1.86B | 8.03% |
| 2013-06-30 | $0.12B | $1.80B | 6.75% |
| 2013-03-31 | $0.12B | $1.78B | 6.91% |
| 2012-12-31 | $-0.19B | $1.78B | -10.93% |
| 2012-09-30 | $-0.05B | $1.76B | -2.85% |
| 2012-06-30 | $-0.03B | $1.69B | -1.58% |
| 2012-03-31 | $-0.04B | $1.72B | -2.00% |
| 2011-12-31 | $0.32B | $1.98B | 16.70% |
| 2011-09-30 | $0.24B | $1.94B | 12.53% |
| 2011-06-30 | $0.22B | $1.95B | 11.71% |
| 2011-03-31 | $0.24B | $1.89B | 13.82% |
| 2010-12-31 | $0.20B | $1.79B | 12.05% |
| 2010-09-30 | $0.16B | $1.72B | 10.07% |
| 2010-06-30 | $0.18B | $1.58B | 11.35% |
| 2010-03-31 | $0.13B | $1.59B | 8.07% |
| 2009-12-31 | $0.30B | $1.59B | 20.18% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.493B | $3.047B |
| Teleflex is a global provider of medical technology products. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company markets and sells its products to hospitals and healthcare providers worldwide through a combination of direct sales force and distributors. Teleflex has manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $188.160B | 22.76 |
| Intuitive Surgical (ISRG) | United States | $171.782B | 71.20 |
| IDEXX Laboratories (IDXX) | United States | $50.940B | 53.01 |
| Edwards Lifesciences (EW) | United States | $46.340B | 30.71 |
| Alcon (ALC) | Switzerland | $44.451B | 29.84 |
| IQVIA Holdings (IQV) | United States | $32.700B | 18.48 |
| DexCom (DXCM) | United States | $31.725B | 47.59 |
| Mettler-Toledo (MTD) | United States | $27.244B | 32.34 |
| STERIS (STE) | Ireland | $24.388B | 25.96 |
| Waters (WAT) | United States | $17.722B | 24.34 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.000B | 0.00 |
| Hologic (HOLX) | United States | $15.084B | 16.34 |
| Penumbra (PEN) | United States | $9.875B | 72.14 |
| Sysmex ADR (SSMXY) | Japan | $8.416B | 26.74 |
| Globus Medical (GMED) | United States | $8.261B | 19.06 |
| Masimo (MASI) | United States | $7.973B | 26.83 |
| Glaukos (GKOS) | United States | $5.221B | 0.00 |
| TransMedics (TMDX) | United States | $4.182B | 63.56 |
| Integer Holdings (ITGR) | United States | $3.723B | 18.58 |
| LivaNova (LIVN) | United Kingdom | $2.920B | 16.71 |
| Alphatec Holdings (ATEC) | United States | $2.338B | 0.00 |
| Veracyte (VCYT) | United States | $2.326B | 32.14 |
| PROCEPT BioRobotics (PRCT) | United States | $2.210B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.118B | 25.29 |
| Artivion (AORT) | United States | $1.983B | 100.05 |
| Elekta AB (EKTAY) | Sweden | $1.850B | 17.30 |
| Integra LifeSciences Holdings (IART) | United States | $1.145B | 6.56 |
| OPKO Health (OPK) | United States | $1.080B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.067B | 0.00 |
| IRadimed (IRMD) | United States | $0.890B | 43.21 |
| Tandem Diabetes Care (TNDM) | United States | $0.736B | 0.00 |
| AxoGen (AXGN) | United States | $0.707B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.690B | 0.00 |
| SiBone (SIBN) | United States | $0.668B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.573B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.530B | 9.37 |
| OrthoPediatrics (KIDS) | United States | $0.480B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.472B | 3.79 |
| Treace Medical Concepts (TMCI) | United States | $0.454B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.390B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.386B | 9.82 |
| Delcath Systems (DCTH) | United States | $0.369B | 88.00 |
| RxSight (RXST) | United States | $0.360B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.359B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.297B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.287B | 19.78 |
| NeuroPace (NPCE) | United States | $0.273B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.265B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.229B | 0.00 |
| Neuronetics (STIM) | United States | $0.223B | 0.00 |
| 908 Devices (MASS) | United States | $0.222B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.215B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.214B | 0.00 |
| Inogen (INGN) | United States | $0.203B | 0.00 |
| CVRx (CVRX) | United States | $0.190B | 0.00 |
| Accuray (ARAY) | United States | $0.170B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.151B | 0.00 |
| LENSAR (LNSR) | United States | $0.149B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.141B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.132B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.108B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.108B | 0.00 |
| InspireMD (NSPR) | United States | $0.101B | 0.00 |
| Hyperfine (HYPR) | United States | $0.099B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.097B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.081B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.075B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.063B | 0.00 |
| Positron (POSC) | United States | $0.058B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.056B | 22.67 |
| EDAP TMS S.A (EDAP) | France | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.053B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.038B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.026B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Tenon Medical (TNON) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (HIND) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.22 |